Understanding the Genetic Link Between Metabolism and Cancer

Researchers recently mapped the onco-metabolic nexus to identify how shared genetics influence malignancy. This large-scale cohort study aims to enhance cancer risk prediction performance by evaluating causal links between metabolic traits and various cancers. Specifically, the analysis suggests that most metabolic traits act as significant risk factors. For instance, the investigation highlighted a strong association between waist-to-hip ratio (WHR) and colorectal cancer (CRC) risk.

Enhancing Cancer Risk Prediction Performance Through Integrative PRS

Furthermore, the team utilized genomic structural equation modeling (gSEM) to identify specific pathways linking metabolic health to oncogenesis. Consequently, they developed integrative polygenic risk score (PRS) models using DBSLMM. These models demonstrate superior predictive accuracy compared to traditional single-score methods. By incorporating pleiotropic genetic information, clinicians can better stratify patient risk in a multispecialty setting. Additionally, local genetic correlation analyses revealed shared biological mechanisms that traditional models often overlook. Therefore, this study provides a genomic roadmap for future targeted interventions in metabolic-driven cancers.

Clinical Implications of the Onco-Metabolic Nexus

Moreover, the study assessed 240 trait-cancer associations to build a comprehensive risk profile. Most metabolic parameters, including obesity markers and glucose levels, showed shared genetic architectures with common cancers. However, the integration of these metabolic signatures into PRS models provides a more nuanced understanding of individual susceptibility. This precision oncology approach allows for earlier screening and more effective population risk stratification. Ultimately, managing metabolic health remains a cornerstone in reducing the global cancer burden.

Frequently Asked Questions

What is the onco-metabolic nexus?

The onco-metabolic nexus refers to the complex web of causal links and shared genetic traits between metabolic health (such as obesity or diabetes) and the development of cancer.

How does this study improve cancer risk prediction performance?

It improves performance by using genomic structural equation modeling (gSEM) to create integrative polygenic risk scores. These scores combine genetic data from multiple metabolic traits, offering higher accuracy than single-trait models.

Which metabolic traits are most strongly linked to cancer?

The study specifically identified waist-to-hip ratio (WHR) as a major risk factor for colorectal cancer. Other metabolic traits related to lipid metabolism and glucose regulation also showed significant pleiotropic links.

Disclaimer: This content is for informational and educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Refer to the latest local and national guidelines for clinical practice.

References

Ji X et al. Profiling the onco-metabolic nexus and improving cancer risk prediction performance: a large-scale cohort and genome-wide pleiotropic analysis. Cancer Res Commun. 2026 Apr 10. doi: 10.1158/2767-9764.CRC-26-0099. PMID: 41962157.

Kachuri L et al. Pan-cancer analysis demonstrates that integrating polygenic risk scores with modifiable risk factors improves risk prediction. Nat Commun. 2020;11(1):6075. doi: 10.1038/s41467-020-19600-4.

Grotzinger AD et al. Genomic structural equation modeling provides insights into the multivariate genetic architecture of complex traits. Nat Commun. 2019;10(1):4650. doi: 10.1038/s41467-019-12669-6.